Tag: Avion Pharmaceuticals
-
New Survey Highlights Pill-Splitting Challenges in Parkinson’s Disease Treatment
Overview A recent study conducted by Avion Pharmaceuticals, a subsidiary of Alora Pharmaceuticals, sheds light on a practical yet often overlooked issue in Parkinson’s disease management: pill-splitting. The survey explores how patients and caregivers cope with dividing medications, the impact on treatment adherence, and the potential consequences for health outcomes. By shining a light on…
-
Pill-Splitting Challenges in Parkinson’s Treatment: New Survey
New Survey Sheds Light on Pill-Splitting in Parkinson’s Disease Treatment A new survey released by Avion Pharmaceuticals, a subsidiary of Alora Pharmaceuticals, highlights a persistent challenge in Parkinson’s disease (PD) management: the need to split pills to manage dosage, timing, and side effects. The findings, drawn from responses of patients, caregivers, and clinicians, underscore how…